Delivery Order SPE2DB20D3103-SPE2DB25FL3R5

Award Date 10/15/24
Potential Completion Date 10/16/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Cinacalcet HCL 30 mg tablets to the Defense Logistics Agency (DLA). The $2,344.77 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 23, 2024 with a completion date of December 24, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
This federal contract award is a delivery order worth $1,161.90 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Cinacalcet HCL 30 mg tablets and has a completion date of February 3, 2025. The contract is not designated as a set-aside and is issued under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,047.36 fixed-price contract is for the delivery of Cinacalcet HCl 30 mg tablets, with a period of performance running through October 17, 2024. The contract is not designated as a set-aside and represents an open competition. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Cinacalcet HCl 30 mg tablets. The contract, valued at $1,563.18, is a firm fixed-price delivery order without any set-aside designation, indicating open competition. The contract has an ultimate completion date of October 16, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cinacalcet HCl 30 mg tablets, a medication used to treat certain types of hyperparathyroidism. The firm-fixed-price contract has a ceiling value of $4,689.54 and is set to expire on January 17, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,774.92 firm fixed-price delivery order is for the supply of Cinacalcet HCl 30 mg tablets. The award is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of CINACALCET HCL 30 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $6,201.58 and a completion date of April 7, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,411.44 and an ultimate completion date of February 19, 2025. It covers the procurement of Cinacalcet HCl 30 mg tablets for federal government medical programs. AmerisourceBergen is an established vendor for the DLA, holding a $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 30 mg Cinacalcet HCl tablets, a medication used to treat certain types of kidney disease. The contract has a ceiling value of $24,719.33 and runs through March 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,524.40 firm fixed-price delivery order is for 4,567,394,905 units of CINACALCET HCL 30 MG TABLET 30S. The contract has a ceiling value of $5,524.40 and a completion date of February 27, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FL3R5
    Delivery Order

The federal contract award is for the delivery of Cinacalcet HCl 30 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Delivery Order worth $2,344.77 and has a firm fixed price pricing structure. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on October 15, 2024, with a period of performance through October 16, 2024. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 9:56 AM